Hamilton Lane Advisors’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-19,898
| Closed | -$147K | – | 48 |
|
|
2019
Q3 | $147K | Hold |
19,898
| – | – | 0.06% | 47 |
|
|
2019
Q2 | $223K | Hold |
19,898
| – | – | 0.11% | 42 |
|
|
2019
Q1 | $214K | Sell |
19,898
-48,855
| -71% | -$525K | 0.11% | 50 |
|
|
2018
Q4 | $1.04M | Sell |
68,753
-12,000
| -15% | -$181K | 0.91% | 23 |
|
|
2018
Q3 | $1K | Hold |
80,753
| – | – | 0.41% | 28 |
|
|
2018
Q2 | $2K | Sell |
80,753
-24,780
| -23% | -$614 | 1.82% | 14 |
|
|
2018
Q1 | $3K | Buy |
105,533
+55,139
| +109% | +$1.57K | 2.38% | 13 |
|
|
2017
Q4 | $1.06M | Buy |
50,394
+22,048
| +78% | +$466K | 0.55% | 35 |
|
|
2017
Q3 | $515K | Buy |
+28,346
| New | +$515K | 0.35% | 37 |
|
|
2017
Q2 | – | Sell |
-21,199
| Closed | -$366K | – | 53 |
|
|
2017
Q1 | $366K | Buy |
+21,199
| New | +$366K | 0.18% | 54 |
|